NO synthesis and signaling in plants - where do we stand?

被引：209
|
作者：
Moreau, Magali [1 ]
Lindermayr, Christian [2 ]
Durner, Joerg [2 ]
Klessig, Daniel F. [1 ]
机构：
[1] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA
[2] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Biochem Plant Pathol, D-5764 Munich, Germany
来源：
PHYSIOLOGIA PLANTARUM | 2010年 / 138卷 / 04期
基金：
美国国家卫生研究院;
关键词：
NITRIC-OXIDE SYNTHASE; S-NITROSYLATED PROTEINS; VERTICILLIUM-DAHLIAE TOXINS; INDUCED STOMATAL CLOSURE; ARABIDOPSIS-THALIANA; NITRATE REDUCTASE; CELL-DEATH; REACTIVE NITROGEN; DEFENSE RESPONSES; NITROSOGLUTATHIONE REDUCTASE;
D O I：
10.1111/j.1399-3054.2009.01308.x
中图分类号：
Q94 [植物学];
学科分类号：
071001 ;
摘要：
Over the past 20 years, nitric oxide (NO) research has generated a lot of interest in various aspects of plant biology. It is now clear that NO plays a role in a wide range of physiological processes in plants. However, in spite of the significant progress that has been made in understanding NO biosynthesis and signaling in planta, several crucial questions remain unanswered. Here we highlight several challenges in NO plant research by summarizing the latest knowledge of NO synthesis and by focusing on the potential NO source(s) and players involved. Our goal is also to provide an overview of how our understanding of NO signaling has been enhanced by the identification of array of genes and proteins regulated by NO.
引用
收藏
页码：372 / 383
页数：12
相关论文
共 50 条
  • [1] Nitric oxide synthase in plants: Where do we stand?
    Santolini, Jerome
    Andre, Francois
    Jeandroz, Sylvain
    Wendehenne, David
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2017, 63 : 30 - 38
  • [2] Maximizing neuroprotection: where do we stand?
    Kuffler, Damien P.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2012, 8 : 185 - 194
  • [3] Statins in Heart Failure-Where Do We Stand?
    Lyons, Kristopher S.
    McVeigh, Gary E.
    Harbinson, Mark T.
    CARDIOVASCULAR DRUGS AND THERAPY, 2011, 25 (01) : 99 - 104
  • [4] Bicuspid aortic valve-associated aortopathy: Where do we stand?
    Messner, Barbara
    Bernhard, David
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2019, 133 : 76 - 85
  • [5] Photodynamic therapy (PDT) for malignant brain tumors Where do we stand?
    Quirk, Brendan J.
    Brandal, Garth
    Donlon, Steven
    Vera, Juan Carlos
    Mang, Thomas S.
    Foy, Andrew B.
    Lew, Sean M.
    Girotti, Albert W.
    Jogal, Sachin
    LaViolette, Peter S.
    Connelly, Jennifer M.
    Whelan, Harry T.
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2015, 12 (03) : 530 - 544
  • [6] The Pivotal Role of Senescence in Cell Death and Aging: Where Do We Stand?
    Mohammad Zeeshan Sadaf
    Vyas Najm
    Moin Shingatgeri
    Mohammad Asrar Uddin
    Md Salman Izhari
    Atul Akhtar
    Subhabrata Kathait
    Ishita Kar
    Pulkit Jain
    Komal Datt
    Anoushka Komal
    Current Molecular Biology Reports, 2020, 6 (2) : 91 - 101
  • [7] Biomarkers Obtained by Non-Invasive Methods in Patients with COPD: Where do we Stand, what do we Expect?
    Hillas, Georgios
    Loukides, Stelios
    Kostikas, Konstantinos
    Bakakos, Petros
    CURRENT MEDICINAL CHEMISTRY, 2009, 16 (22) : 2824 - 2838
  • [8] Cardioprotective Utility of Urocortin in Myocardial Ischemia-Reperfusion Injury: Where do We Stand?
    Basman, Craig
    Agrawal, Pratik
    Knight, Richard
    Saravolatz, Louis
    Mcree, Chad
    Chen-Scarabelli, Carol
    Narula, Jagat
    Scarabelli, Tiziano
    CURRENT MOLECULAR PHARMACOLOGY, 2018, 11 (01) : 32 - 38
  • [9] Autophagic flux control in neurodegeneration: Progress and precision targeting-Where do we stand?
    Lumkwana, Dumisile
    du Toit, Andre
    Kinnear, Craig
    Loos, Ben
    PROGRESS IN NEUROBIOLOGY, 2017, 153 : 64 - 85
  • [10] Expansion and innovation in auxin signaling: where do we grow from here?
    Baez, Roman Ramos
    Nemhauser, Jennifer L.
    DEVELOPMENT, 2021, 148 (05):
12345